We served as lead counsel representing an addiction treatment company alleging that defendants prescribed Suboxone when not medically indicated, ordered unnecessary urine drug testing, and billed for higher levels of care than provided. We persuaded DOJ to decline intervention. The relator voluntarily dismissed the case.